Are You Getting All The Information From The Doctor?

When a patient visits a doctor, they will be informed of risks and side effects regarding medications and surgery. Consent from the patient is required in order to receive any type of treatment or medication; however, when it comes to vaccinations, doctors do not tell all – simply because they do not know all the risks associated with vaccines and are not required to tell patients.

In the United States, there are no governmental requirements for informed consent for vaccination. This raises a red flag in terms of information because a mass-marketed vaccination like the HPV vaccine has insufficient data and research on how it can affect the body – leaving many patients in the dark.

Funded researchers of Children’s Medical Safety Research Institute have drawn the line of this ethical dilemma through studies conducted by Lucija Tomljenovic and Christopher Shaw. HPV vaccinations are often promoted by the world’s leading medical authorities, saying the HPV vaccines are an important cervical cancer prevention tool, yet clinical trials show no evidence that HPV vaccination can protect against cervical cancer.

In other parts of the globe, patients receive more information than their American counterparts but this poses the question – do those doctors fully understand the risks? In the United Kingdom, guidelines pertaining to vaccination practices state that patients must be given adequate information on which to base their decision on whether to accept or refuse a vaccine. What’s alarming is the lack of sufficient scientific research.

As HPV vaccines are claimed to prevent cervical cancer – it still remains unproven. The death rate of cervical cancer stands at 1.7 out of 100,000 according to the World Health Organization. But, the rate of serious adverse reactions to the HPV vaccine stands at 4.3 out of 100,000. A serious adverse reaction would include deaths, hospitalizations or permanent alterations in health status. In theory, the HPV vaccine is causing 2.5 times more SAE’s than deaths from cervical cancer. Is the risk worth an unproven benefit? Since the vaccine does not eliminate the need for Pap smears due to the possibility that other strains might cause HPV infections, there is certainly no cost benefit to HPV vaccines.

Cervical cancer is preventable by Pap smears and Loop Electrosurgical Excision Procedure (LEEP), which have been proven to be safe and effective. But, how can HPV vaccines be justified without sufficient data?

Tomlijenovic and Shaw pointed out the safety assessment of the HPV vaccine clinical trials. Merck, a pharmaceutical company with the branded vaccine Gardasil, conducted clinical trials that used an aluminum-containing placebo and their product that also contains aluminum adjuvants. The trials showed that a large portion of the adverse reactions from the HPV vaccine were due to the effect of the aluminum adjuvants – a neurotoxin.

Contrary to claims that cervical cancer is the second most common cancer in women worldwide, existing data shows that this only applies to developing countries. With this in mind, HPV vaccines are the most expensive vaccines on the market, making it unlikely that those developing countries would ever benefit from them.

French Parliament Investigates HPV Vaccination Campaigns

A three hour debate in Paris concerning the safety, efficacy and necessity of HPV vaccines in French cervical cancer prevention programs was presented to the French Parliament, French Senate, health authorities, medical professionals and the public in May. This discussion was the first time a western government has called experts to testify about the adverse reactions to vaccines.

The debate was spurred by an open letter to the French Minister of Health calling for investigative action towards various aspects of HPV vaccination campaigns. The letter was signed by more than 200 medical professionals, confirming their agreement about safety concerns regarding the vaccines.

CMSRI funded researchers from around the world were in attendance at the debate to weigh in on this hot topic. They shed light on various issues to the discussion board about aluminum adjuvants and human papillomavirus, also known as HPV.

A member of the European Parliament opened the meeting with a speech that stated research findings and the actions necessary to protect the public health. Michele Rivasi opened with – Vaccines are unnecessary, dangerous to many and certainly a huge drain on public health funds.

Rivasi mentioned CMSRI advisory board members and funded researchers during her opening speech by highlighting the findings from Christopher Shaw, Lucija Tomljenovic, Stephanie Seneff, Yeduda Shoenfeld, Chris Exley, and Romain Gherardi – blaming the toxicity of aluminum salts used as adjuvants in vaccines cause adverse reactions.

The injection of aluminum salts could be the source of the unexplained “increase in the number of pathologies reported because they migrate through the body until they reach and accumulate in the brain.  In certain predisposed individuals, very serious adverse effects have been observed following vaccination: death, convulsions, fainting, autistic disorders, Guillain-Barre syndrome, transverse myelitis, facial paralysis, chronic fatigue syndrome, autoimmune diseases, pulmonary embolisms, macrophagic myofasciitis, pancreatitis and others.”

After Rivasi continued with other statements, she urged the need of extensive research before the parliament continues to vaccinate. Finishing with – research before consent, you can’t unvaccinate.

The discussion led to four round tables where CMSRI researchers presented their findings to the French Parliament and others, making the open forum history. The open conversation in Paris is paving the way for other countries to examine the risks vaccines pose on health.